TGA Approval

TAFINLAR dabrafenib (as mesilate) 50 mg capsule bottle (200922)

ARTG ID

200922

ARTG Name

TAFINLAR dabrafenib (as mesilate) 50 mg capsule bottle

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

August 27, 2013

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/d33b56f8f05e1ac1636ed39cd5e0d785.pdf

https://medical-cdn.nocode.com/drug_tga/d06bfbdd76c8880e926f60b6150e8c9a.pdf

Ingredient Name

dabrafenib mesilate

Empowering clinical research with data-driven insights and AI-powered tools.

TAFINLAR dabrafenib (as mesilate) 50 mg capsule bottle (200922) - TGA 批准文号 | MedPath